Dualitas Therapeutics

About Dualitas Therapeutics

Dualitas Therapeutics is a biotechnology company pioneering the future of bispecific antibody therapies for immune and inflammatory (I&I) diseases and beyond. Powered by our proprietary DualScreen™ discovery engine and a growing library of novel cell surface proximity engagers, our pipeline—including lead programs DTX-103 and DTX-102—has demonstrated compelling preclinical evidence supporting its potential to address important unmet patient needs. We offer partnering opportunities on the next generation of bispecific therapies in I&I diseases – and beyond. Dualitas Therapeutics has been made aware of fraudulent recruiting activity in which individuals falsely claim to represent our company. These scammers may offer fake job opportunities and attempt to collect personal or financial information. All legitimate communication from Dualitas comes from email addresses ending in @dualitastx.com. Dualitas does not conduct interviews through text or messaging apps, does not ask candidates to download software, does not request payments or financial information, and does not issue job offers without in-person interviews.